⌘K

t

RNS Metadata

Date	7 Feb 2022
Time	10:30:58
Category	Results
ID	8871A

/Equities/XLON/GSK/RNS

Publication of full year 2021 results: Replacement

RNS Number : 8871A

GlaxoSmithKline PLC

07 February 2022

GlaxoSmithKline plc

The following amendment has been made to the Publication of full year 2021 results announcement released on 7 February 2022 at 10:00am under RNS No 8776A.

The announcement date will be Wednesday 9 February 2022.

All other details remain unchanged.

The full amended text is shown below.

Publication of full year 2021 results

GlaxoSmithKline plc will announce its full year and fourth quarter 2021 results to the London Stock Exchange at 07:00 GMT on Wednesday 9 February 2022.

Analysts and investors are invited to participate in a conference call and webcast, including a presentation of the results and a Q&A session. This event will take place on the same day at 14:00 GMT.

To participate, please join the live audio webcast, which can be accessed directly via the website. The presentation will also be available on the website about one hour before the event's start.

V A Whyte

Company Secretary

7 February 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOREAEAXEAKAEFA

RNS Metadata

Date	7 Feb 2022
Time	10:30:58
Category	Results
ID	8871A

RNS Number : 8871A

GlaxoSmithKline PLC

07 February 2022

GlaxoSmithKline plc

The following amendment has been made to the Publication of full year 2021 results announcement released on 7 February 2022 at 10:00am under RNS No 8776A.

The announcement date will be Wednesday 9 February 2022.

All other details remain unchanged.

The full amended text is shown below.

Publication of full year 2021 results

GlaxoSmithKline plc will announce its full year and fourth quarter 2021 results to the London Stock Exchange at 07:00 GMT on Wednesday 9 February 2022.

Analysts and investors are invited to participate in a conference call and webcast, including a presentation of the results and a Q&A session. This event will take place on the same day at 14:00 GMT.

To participate, please join the live audio webcast, which can be accessed directly via the website. The presentation will also be available on the website about one hour before the event's start.

V A Whyte

Company Secretary

7 February 2022

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

NOREAEAXEAKAEFA

TIDM	GSK
Share Price	Loading...
Market Cap	Loading...

TIDM	GSK
Share Price	Loading...
Market Cap	Loading...

t

t

Company Information

RNS Metadata

Publication of full year 2021 results: Replacement

Company Information

RNS Metadata